Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis

Clinical and Experimental Immunology

Volumn 155, Issue 3, 2009, Pages 457-465

  Arakelyan, A ^a,b   Kriegova, E ^a   Kubistova Z ^a   Mrazek, F ^a   Kverka, M ^c   Du Bois, R M ^d   Kolek, V ^e   Petrek, M ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Bronchoalveolar lavage fluid; Chemokines; Cytokines; L fgren's syndrome; Matrix metalloproteinases

Indexed keywords

BETA CHEMOKINE; CC CHEMOKINE LIGAND 15; CC CHEMOKINE LIGAND 16; CXCL9 CHEMOKINE; CYTOKINE; EOTAXIN 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR; INTERLEUKIN 16; INTERLEUKIN 8; MACROPHAGE ACTIVATING FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; MATRIX METALLOPROTEINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LUNG LAVAGE; MACROPHAGE MIGRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; REGULATORY MECHANISM; SAMPLING; SARCOIDOSIS; THORAX RADIOGRAPHY; UPREGULATION;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHEMOKINES, CC; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE INFLAMMATORY PROTEINS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; SARCOIDOSIS, PULMONARY; UP-REGULATION; YOUNG ADULT;

EID: 59249091965     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03832.x     Document Type: Article

References (36)

1. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003 361 : 1111 18.
2. Kolek V. Sarcoidosis: known and unknown [in Czech]. Prague : Grada Publishing, 1998.
3. American Thoracic Society, European Respiratory Society, World Association of Sarcoidosis and Other Granulomatous Disorders. Joint statement on sarcoidosis. Am J Respir Crit Care Med 1999 160 : 736 55.
4. Zissel G, Prasse A, Müller-Quernheim J. Sarcoidosis - immunopathogenetic concepts. Semin Respir Crit Care Med 2007 28 : 3 14.
5. Agostini C, Trentin L, Facco M et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996 157 : 910 18.
6. Gibejova A, Mrazek F, Subrtova D et al. Expression of macrophage inflammatory protein-3 beta/CCL19 in pulmonary sarcoidosis. Am J Respir Crit Care Med 2003 167 : 1695 703.
7. Petrek M, Kolek V, Szotkowská J et al. CC and C chemokine expression in pulmonary sarcoidosis. Eur Respir J 2002 20 : 1206 12.
8. Kriegova E, Melle C, Kolek V et al. Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2006 173 : 1145 54.
9. Pease JE, Williams TJ. The attraction of chemokines as a target for specific anti-inflammatory therapy. Br J Pharmacol 2006 147 (Suppl. 1 S212 21.
10. Gurrieri C, Bortoli M, Brunetta E et al. Cytokines, chemokines and other biomolecular markers in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 (Suppl. 1 S9 14.
11. McDonnell S, Morgan M, Lynch C. Role of matrix metalloproteinases in normal and disease processes. Biochem Soc Trans 1999 27 : 734 40.
12. Calandra T, Bucala R. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 1997 17 : 77 88.
13. Wang MH, Zhou YQ, Chen YQ. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Scand J Immunol 2002 56 : 545 53.
14. Chapman JT, Mehta AC. Bronchoscopy in sarcoidosis: diagnostic and therapeutic interventions. Curr Opin Pulm Med 2003 9 : 402 7.
15. Sugiyama K, Mukae H, Ishii H et al. Elevated levels of interferon gamma-inducible protein-10 and epithelial neutrophil-activating peptide-78 in patients with pulmonary sarcoidosis. Respirology 2006 11 : 708 14.
16. Center DM, Berman JS, Kornfeld H et al. The lymphocyte chemoattractant factor. J Lab Clin Med 1995 125 : 167 72.
17. Ziegenhagen MW, Schrum S, Zissel G et al. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Invest Med 1998 46 : 223 31.
18. Henry MT, McMahon K, Mackarel AJ et al. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J 2002 20 : 1220 7.
19. O'Connor C, Odlum C, Van Breda A et al. Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax 1988 43 : 393 400.
20. Noor A, Knox KS. Immunopathogenesis of sarcoidosis. Clin Dermatol 2007 25 : 250 8.
21. Ziegenhagen MW, Müller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 2003 253 : 18 30.
22. Suga M, Iyonaga K, Ichiyasu H et al. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 1999 14 : 376 82.
23. Navratilova Z, Mrazek F, Kriegova E et al. The MCP-1-2518 (A to G) single nucleotide polymorphism in Czech patients with pulmonary sarcoidosis: association with Löfgren's syndrome. Sarcoidosis Vasc Diffuse Lung Dis 2007 24 : 33 8.
24. Keane MP, Standiford TJ, Strieter RM. Chemokines are important cytokines in the pathogenesis of interstitial lung disease. Eur Respir J 1997 10 : 1199 202.
25. Skeel A, Leonard EJ. Action and target cell specificity of human macrophage-stimulating protein (MSP). J Immunol 1994 152 : 4618 23.
26. Sakamoto O, Iwama A, Amitani R et al. Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility. J Clin Invest 1997 99 : 701 9.
27. Brunelleschi S, Penengo L, Lavagno L et al. Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin. Br J Pharmacol 2001 134 : 1285 95.
28. Gunella G, Bardelli C, Amoruso A et al. Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-kappaB pathway. Br J Pharmacol 2006 148 : 478 89.
29. Schürmann M, Reichel P, Müller-Myhsok B et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001 164 : 840 6.
30. Pardigol A, Forssmann U, Zucht HD et al. HCC-2, a human chemokine: gene structure, expression pattern, and biological activity. Proc Natl Acad Sci USA 1998 95 : 6308 13.
31. Youn BS, Zhang S, Broxmeyer HE et al. Isolation and characterization of LMC, a novel lymphocyte and monocyte chemoattractant human CC chemokine, with myelosuppressive activity. Biochem Biophys Res Commun 1998 247 : 217 22.
32. Youn BS, Zhang SM, Broxmeyer HE et al. Characterization of CKbeta8 and CKbeta8-1: two alternatively spliced forms of human beta-chemokine, chemoattractants for neutrophils, monocytes, and lymphocytes, and potent agonists at CC chemokine receptor 1. Blood 1998 91 : 3118 26.
33. Haringman JJ, Smeets TJ, Reinders-Blankert P et al. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 2006 65 : 294 300.
34. Ziegenhagen MW, Rothe ME, Schlaak M et al. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003 21 : 407 13.
35. Tutor-Ureta P, Citores MJ, Castejón R et al. Prognostic value of neutrophils and NK cells in bronchoalveolar lavage of sarcoidosis. Cytometry B Clin Cytom 2006 70 : 416 22.
36. Cappello P, Caorsi C, Bosticardo M et al. CCL16/LEC powerfully triggers effector and antigen-presenting functions of macrophages and enhances T cell cytotoxicity. J Leukoc Biol 2004 75 : 135 42.